11beta-hydroxysteroid dehydrogenase type 1 inhibitor AZD4017

From Encyclopedia & World Directory
Jump to navigation Jump to search

A selective, orally bioavailable inhibitor of the enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11b-HSD1; 11bHSD1; HSD11B1), with potential protective activity. Upon administration, AZD4017 selectively binds to and inhibits the activity of 11b-HSD1. This prevents the conversion of cortisone to the active hormone cortisol that activates glucocorticoid receptors. By blocking cortisol production in metabolic tissues, AZD4017 may inhibit the adverse metabolic effects, such as glucose intolerance, hyperinsulinemia, systolic hypertension, increased adiposity, myoatrophy and dermal atrophy, caused by exogenous administration of glucocorticoids in these tissues. 11bHSD1 is highly expressed in metabolic tissues, such as liver, skeletal muscle, and adipose tissue. It plays a crucial role in regenerating active glucocorticoid from circulating glucocorticoids and regulates the production of cortisol to activate the glucocorticoid receptors. AZD4017 does not inhibit the anti-inflammatory activity of the administered glucocorticoids.

Resources

Latest articles - 11beta-hydroxysteroid dehydrogenase type 1 inhibitor AZD4017

PubMed
Clinical trials

Navigation: Wellness - Health Encyclopedia - Health topics - Disease Index‏‎ - Cases - Drugs - Rare diseases - Gray's Anatomy - USMLE - All Pages

World directories: Doctors - Healthsites - Hospitals - Medical schools

WikiMD's articles are provided for informational purposes, and is not a substitute for professional medical advice. See full disclaimer.

Tired of being Overweight? Want to lose weight with insurance?
Try W8MD's physician weight loss - Philadelphia weight loss & NYC lose weight.